Abstract:We read with great interest the article by Onuma et al. [1] which evaluated the long-term safety and efficacy of ABSORB bioasorbable everolimus-eluting stent (BVS) scaffold. The investigators of the study have made pioneering contributions to the assessment of bioresorbable scaffolds. It was concluded that sustained safety could be achieved after the implantation of a fully bioresorbable Absorb everolimus-eluting scalffold with a low event rate at 5 years. Besides, the ABSORB Cohort A trial confirmed the feasibility of noninvasive anatomic and functional assessment of the scaffold with the use of multislice computed tomography (MSCT) angiography and MSCT-based fractional flow reserve (FFR) assessment. However, we have several concerns with regard to the study. First, we have to notice that noninvasive FFR analysis was feasible only in 13 patients. The limited size has weakened the reliability of noninvasive FFR performance in assessing functional outcome of ABSORB BVS. Good image quality of all coronary arteries and accurate lumen boundary descriptions are essential for the noninvasive FFR interpretation [2]. Although published reports suggested that CT derived FFR (FFRCT) accuracy was less affected by MSCT image quality than CT stenosis [3], there were four patients (22.2%) who cannot have FFRCT analysis due to severe artifact. Besides, in those with feasible FFRCT, numerous artifacts including calcification, motion, and misregistration may also affect MSCT performance and lead to inaccurate anatomic models for FFRCT computation [4]. Thus, the feasibility and precision of FFRCT need to be further improved. It is not appropriate to use FFRCT alone as a hemodynamic parameter in functional coronary stenosis measurement. Second, a fly in the ointment of the study was the absence of invasive FFR as a reference against noninvasive FFRCT at 5 years. Despite Onuma et al. demonstrated several reasons that they decided to perform repeat MSCT alone instead of invasive imaging, we cannot deny the fact that no published convincing trial exists for FFRCT in the evaluation of interventional treatment [4], although the DISCOVER-FLOW study [5] validated that the FFRCT had a good correlation with an invasive FFR, and the DeFACTO trial [6] demonstrated that the FFRCT plus CT was superior to CT alone as a measure of coronary computed tomography angiography (CCTA) stenosis severity for determination of lesion-specific ischemia. Finally, in the study, angiographic reference standard of the vessel lumen area was derived from MSCT analysis instead of invasive coronary angiography [1]. It is important, however, to note that there is an overestimation of stenosis severity identified by CCTA and even among severe stenosis confirmed by invasive coronary angiography, only a minority cause ischemia [4,6]. Therefore, the possible deviation resulted from the inaccurate reference of MSCT may make the results less convincible.

Intra- and interstudy reproducibility of coronary artery diameter measurements in magnetic resonance coronary angiography.

Reproducibility of Coronary Artery Diameter Assessments in Magnetic Resonance Coronary Angiography: Phantom Study

Reproducibility of adenosine stress cardiovascular magnetic resonance in multi-vessel symptomatic coronary artery disease

Intra- and Inter-Reader Reproducibility in Quantitative Coronary Plaque Analysis on Coronary Computed Tomography Angiography

Interstudy reproducibility of quantitative perfusion cardiovascular magnetic resonance.

Inter-and Intra-Observer Reproducibility of 3.0 T High-Resolution Magnetic Resonance Imaging for Evaluating Atherosclerotic Stenosis in the Middle Cerebral Artery

Measurement of Regional Aortic Compliance by MR Imaging: a Study of Reproducibility.

Challenges in Multislice Computed Tomography Based Fractional Flow Reserve to Evaluate Interventional Treatment

Scan-Rescan Reproducibility of High Resolution Magnetic Resonance Imaging of Atherosclerotic Plaque in the Middle Cerebral Artery.

Scan-rescan Reproducibility of Quantitative Assessment of Inflammatory Carotid Atherosclerotic Plaque Using Dynamic Contrast-Enhanced 3T CMR in a Multi-Center Study

A Novel Three‐dimensional Quantitative Coronary Angiography System: In‐vivo Comparison with Intravascular Ultrasound for Assessing Arterial Segment Length

MDCT Interpretation of the Ascending Aorta with Semiautomated Measurement Software: Improved Reproducibility Compared with Manual Techniques.

Validation of bedside manual versus automated measurements of brain arterial diameters from MR angiography

Interscan Reproducibility of Quantitative Coronary Plaque Volume and Composition from CT Coronary Angiography Using an Automated Method

Reproducibility of CT measurements of aortic valve calcification, mitral annulus calcification, and aortic wall calcification in the multi-ethnic study of atherosclerosis

Reproducibility Assessment of Rapid Strains in Cardiac MRI: Insights and Recommendations for Clinical Application

Accuracy and Reproducibility of Coronary Angiography-Derived Fractional Flow Reserve in the Assessment of Coronary Lesion Severity

3D Whole-Brain Vessel Wall Cardiovascular Magnetic Resonance Imaging: a Study on the Reliability in the Quantification of Intracranial Vessel Dimensions

Reproducibility of Simultaneous Imaging of Intracranial and Extracranial Arterial Vessel Walls Using an Improved T1-weighted DANTE-SPACE Sequence on a 3 T MR System.

Reproducibility of coronary artery calcified plaque with cardiac 64-MDCT: the Multi-Ethnic Study of Atherosclerosis

Reproducibility of 3.0T High-Resolution Magnetic Resonance Imaging for the Identification and Quantification of Middle Cerebral Arterial Atherosclerotic Plaques